Microbix Biosystems Inc. (TSX:MBX)
Canada
· Delayed Price · Currency is CAD | Market Cap | 34.51M |
| Revenue (ttm) | 16.76M |
| Net Income (ttm) | -4.27M |
| Shares Out | 138.02M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 195,500 |
| Average Volume | 72,972 |
| Open | 0.255 |
| Previous Close | 0.260 |
| Day's Range | 0.250 - 0.255 |
| 52-Week Range | 0.210 - 0.410 |
| Beta | 0.51 |
| RSI | 54.52 |
| Earnings Date | May 14, 2026 |
About Microbix Biosystems
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of p... [Read more]
Financial Performance
Financial StatementsNews
Microbix Product Results Being Presented at 2026 PASCV
MISSISSAUGA, ON / ACCESS Newswire / April 27, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that one of its client...
Microbix Engages with Diagnostics Industry Experts
Releasing Episodes of Season Two of "Diagnostics: Beyond the Lab" Podcast MISSISSAUGA, ON / ACCESS Newswire / April 20, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life scien...
Microbix Presenting at the 2026 Bloom Burton Conference
MISSISSAUGA, ON / ACCESS Newswire / April 16, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending ...
Microbix Exhibiting & Presenting at ESCMID Global 2026
Presenting Results of Novel Product for Quality Control of RNA-based Assays MISSISSAUGA, ON / ACCESS Newswire / April 15, 2026 / Microbix Biosystems Inc. (TSX: MBX)(OTCQX:MBXBF, Microbix®), a life sc...
Microbix Announces Annual Meeting Voting Results
MISSISSAUGA, ON / ACCESS Newswire / March 26, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQB:MBXBF) ("Microbix® " or the Company"), a life sciences innovator, manufacturer, and exporter, announces th...
Microbix Presents Reference-Material Innovations at EUROGIN
QUANTDx Samples with "Normalized" Viral Loads for Validating HPV Assays MISSISSAUGA, ON / ACCESS Newswire / March 17, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF)(Microbix®), a life science...
Microbix's Clot-Buster Drug Project Advances
Drug Substance Manufacturing Methods Modernized MISSISSAUGA, ON / ACCESS Newswire / March 10, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacture...
Microbix Announces Issuance of Stock Options
Using Shareholder-Approved Plan to Incentivize and Retain MISSISSAUGA, ON / ACCESS Newswire / February 24, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator...
Microbix Biosystems Earnings Call Transcript: Q1 2026
Q1 2026 revenue rebounded 13% sequentially to CAD 4.2 million, with net loss managed by cash reserves. Growth in QAPs and new client wins offset ongoing weakness in China, while annual revenue is targeted at CAD 18.5–19 million. NCIB share buybacks continue at 15,000 shares per day.
Microbix Reports Results for Q1 2026
Q1 Revenues of $4.2 million and Controlled Net Loss MISSISSAUGA, ON / ACCESS Newswire / February 12, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manu...
Microbix Welcomes The College of American Pathologists as a Client For Supply of QAPs for PT/EQA Programs
MISSISSAUGA, ON / ACCESS Newswire / February 10, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, is pleased to welcome the Co...
Microbix Schedules Release of Results for Q1 Fiscal 2026
Results Release and Webinar Discussion on Morning of February 12, 2026 MISSISSAUGA, ON / ACCESS Newswire / February 5, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF)(Microbix®), a life scienc...
Microbix Presents Molecular Pathology Platform Results
Novel Quality Controls to Enable QC & Inter-Laboratory Standardization MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life science...
Microbix Updates Investor Presentation on its Website
In Response to OSC Requirements to Explain EBITDA (a non-IFRS measure) MISSISSAUGA, ON / ACCESS Newswire / January 9, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life science...
Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing
MISSISSAUGA, ON / ACCESS Newswire / January 7, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial usage...
Microbix Biosystems Earnings Call Transcript: Q4 2025
Revenue declined 27% year-over-year due to major client losses and the absence of Kinlytic sales, but operational improvements and new product launches position the company for a strong recovery in fiscal 2026. Cash reserves remain robust, and share buybacks will continue.
Microbix Schedules Release of Results for Q4 Fiscal 2025
Results Release and Webinar Discussion on Morning of December 18, 2025 Results Release and Webinar Discussion on Morning of December 18, 2025
Microbix Launches New Products to Support H3N2 Flu Testing
MISSISSAUGA, Ontario, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial l...
Microbix & Seegene Mexico Collaborate to Improve Test Accuracy
Making HPV Tests & Quality Assessment Products Available across Mexico Making HPV Tests & Quality Assessment Products Available across Mexico
Microbix Presenting at Muskoka Capital Event
MISSISSAUGA, Ontario, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be ...
Microbix Assisting EMQN with Second Genetic-Test EQA Program
MISSISSAUGA, Ontario and MANCHESTER, United Kingdom, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and expo...
Microbix Client Labquality Introduces Novel EQA Scheme at ESCV
Supporting Clinical Labs in Accurately Identifying HPV-associated Head and Neck Cancers Supporting Clinical Labs in Accurately Identifying HPV-associated Head and Neck Cancers
Microbix Hosts Ontario Minister Stephen Crawford
Site Visit & Discussions at Biotech Manufacturing Facilities in Mississauga Site Visit & Discussions at Biotech Manufacturing Facilities in Mississauga
Microbix Biosystems Earnings Call Transcript: Q3 2025
Q3 fiscal 2025 saw a sharp revenue decline and net loss due to setbacks with two major clients, but recurring sales and key business lines excluding those clients showed double-digit growth. Management is focused on rebuilding sales, launching new products, and leveraging strong liquidity to support recovery.
Microbix Reports Results for Q3 Fiscal 2025
MISSISSAUGA, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its th...